Results  1 - 20 of 23

View all
< Prev
Date Topic
23/1/2012Freshfields advises Roche Diagnostics on manufacturing and supply agreement with Altek
9/1/2012Freshfields advises on first UK PFI monoline replacement
3/10/2011Freshfields advises Capita Asset Services as special servicer of the lenders to NHP in connection with the restructuring of Southern Cross Healthcare Group PLC
26/5/2011News release - Freshfields advises AB Sanitas on Valeant Pharmaceuticals sale for €314m
23/5/2011Freshfields advises on sale of Russian/CIS pharma assets to Johnson & Johnson
19/5/2011Freshfields advises on 9.6bn Euro private equity pharma deal
19/5/2011Freshfields advises Cinven on $3.5bn disposal of Phadia
4/4/2011More than half of the UK’s largest companies welcome scrapping the default retirement age but almost two thirds fear potential damage to economic recovery and job creation
28/2/2011Freshfields appoints global CMO
13/1/2011Freshfields tops M&A league tables for 2010
10/1/2011Freshfields appoints new regional managing partner for Asia
10/1/2011Freshfields advises Merck KGaA on the sale of Théramex to Teva
23/12/2010EU Cartel settlements near record with more than €3 billion in penalties delivered in 2010
20/12/2010Cross-border acquisitions by UK companies reach highest share in 10 years
17/12/2010Europe proves valuable hunting ground for US bribery investigations with nearly $1.5 billion in penalties collected from EU companies this year
19/10/2010Widespread industrial action across the private sector is unlikely, according to Freshfields Bruckhaus Deringer
30/9/2010Freshfields elects new international leadership team
6/8/2010Fewer corporate insolvencies but company voluntary arrangements rise by almost 50% and real estate and construction account for more than half of larger cases
23/4/2010Freshfields elects nine to counsel role
29/3/2010Freshfields elects 18 in new generation of partners

News

Freshfields advises Roche Diagnostics on manufacturing and supply agreement with Altek View

Freshfields advises on first UK PFI monoline replacement View

Briefings

Life sciences: China  View

Class actions in the EU: a threat to the life sciences industry?  View

Contact